Latest Breaking News On - Stelis biopharma ltd - Page 2 : vimarsana.com

Syngene reports strong second quarter results: Revenue from operations up 18 5% to Rs 910 crores, PAT (before exceptional items) up 20% to Rs 122 crores

Mumbai: Syngene International Limited today announced its second quarter and half year financial results. Reported revenue from operations for the quarter was up 18.5% year-on-year to Rs. 910 crores, around 15% at constant currency. Profit after tax

Andhra pradeshSibaji biswasJonathan huntStelis biopharmaDevelopment servicesManufacturing servicesSyngene internationalDrug administrationDiscovery servicesStelis biopharma ltdWhile the companySyngene international limitedManaging directorChief executive officerQuality controlDedicated centers

Global COVID-19 Competitive Landscape Report 2023: Comprehensive Insights on 400+ Companies and 500+

DUBLIN (BUSINESS WIRE) The "COVID-19 - Competitive Landscape, 2023" report has been added to ResearchAndMarkets.com's offering.This "COVID-19 Competitive landscape 2023" report provides comprehensive insights about 400+ companies and 500+ drugs in COVID-19 Competitive landscape. It covers the therapeutics assessme.

United statesRepublic ofNanogen nanocovaxAkston biosciencesLaura woodArchivel farmaIntsel chimosSiemens healthineersAsia pacificZerun bioAkston biosciences corpand biolexisWestvac biopharmaTeva pharmaAdvagene biopharmaGilead sciencesHuahui health

TPG-backed firm to absorb Indian drugmaker s contract development biz, go public

An Indian biopharmaceutical company that counts private equity firm TPG as an investor will absorb a local drugmaker’s contract development and manufacturing organisation (CDMO) and ..

Stelis biopharma ltdTpg growthStelis biopharmaStrides pharma science ltdOman india joint investment fundRoute oneThink investmentsSyngene international ltdHms holdingsSumit upadhyayaM amp a

Syngene Revenue Up 26% To ₹832 Cr, PAT Up 26% To ₹93 Cr In Q1FY24

Syngene Revenue Up 26% To ₹832 Cr, PAT Up 26% To ₹93 Cr In Q1FY24
freepressjournal.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from freepressjournal.in Daily Mail and Mail on Sunday newspapers.

Andhra pradeshSibaji biswasJonathan huntStelis biopharma ltdManufacturing servicesSyngene international limited onDrug administrationDiscovery servicesSyngene internationalSyngene international limitedManaging directorChief executive officerChief financial officer

Syngene s Q1 net profits up 26% to ₹93 crore - The Hindu BusinessLine

Syngene s Q1 net profits up 26% to ₹93 crore - The Hindu BusinessLine
thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.

Andhra pradeshJonathan huntSibaji biswasDiscovery servicesSyngene internationalStelis biopharma ltdDrug administrationManufacturing servicesDedicated centersManaging directorChief executive officerChief financial officer